Tilray Inc. ($TLRY) Stock Forecast: Down 23.1% Today

What is Tilray Inc.?

Tilray Brands (TLRY) has garnered attention in the market recently due to speculation about potential changes in marijuana regulations, notably the reclassification from Schedule I to Schedule III.

Why is Tilray Inc. going down?

TLRY stock is down 23.1% on Dec 19, 2025 14:41

• Today's bearish movement in TLRY may be due to investors taking profits following a recent surge influenced by discussions of President Trump contemplating cannabis reclassification.
• Though there is optimism about regulatory changes, the speculative nature of the cannabis industry and uncertainties regarding federal legalization may be causing some traders to proceed with caution.
• Volatility in TLRY's stock price could be impacted by option traders anticipating significant year-end movements, leading to short-term market fluctuations.
• It is important for investors to stay informed about any official announcements on cannabis regulations to navigate the current market volatility effectively.

TLRY Price Chart

TLRY Technical Analysis

TLRY News

Tilray Brands (TLRY) Stock News Today: Trump Cannabis Rescheduling Reports Fuel Volatility, Fresh Forecasts and Key Levels (Dec. 17, 2025)

Tilray Brands (TLRY) stock experienced significant volatility on December 17, 2025, surging 27% amidst renewed speculation that President Donald Trump might issue an executive order to reclassify cannabis at the federal level to Schedule III. While this move could potentially reduce taxes, ease banking restrictions, and allow for more research, experts caution that it does not equate to federal legalization. The stock's recent 1-for-10 reverse split and the highly speculative nature of cannabis regulatory news are contributing to its large price swings, with option traders forecasting substantial moves by year-end and beyond.

https://ts2.tech/en/tilray-brands-tlry-stock-news-today-trump-cannabis-rescheduling-reports-fuel-volatility-fresh-forecasts-and-key-levels-dec-17-2025/

Pot stocks pop on Schedule 3 hopes: Tilray Brands, Trulieve Cannabis, Cresco Labs: How high will they go?

Shares of publicly traded cannabis companies, including Tilray Brands, Trulieve Cannabis, and Cresco Labs, are experiencing significant gains following reports that the Trump administration is considering reclassifying marijuana from a Schedule I to a Schedule III drug. While President Trump has indicated he is "considering" the reclassification to facilitate research, no official decision has been made. This potential change, which would lessen restrictions but not alter federal legality, has already led to impressive stock jumps for several major cannabis brands.

https://www.fastcompany.com/91461972/pot-stocks-price-rise-tilray-trulieve-cannabis-cresco-schedule-3-news

Stock Market Today, Dec. 16: Tilray Brands Surges 27.5% After Trump Signals Possible Marijuana Reclassification

Tilray Brands saw a significant 27.5% surge on December 16, 2025, following signals from former President Donald Trump regarding a possible reclassification of marijuana. This news led to a sector-wide cannabis rally, with other companies like Canopy Growth and Cronos Group also experiencing gains. The potential reclassification from a Schedule I to a Schedule III drug could expand the addressable market for cannabis producers like Tilray, allowing for medical use under federal law.

https://finance.yahoo.com/news/stock-market-today-dec-16-222038850.html

Option Traders Are Pricing a Nearly 22% Move in Tilray Stock Before the End of 2025. Should You Buy, Sell, or Hold TLRY Here?

Tilray (TLRY) shares recently surged 30% due to President Trump's consideration of reclassifying cannabis as a Schedule III drug and authorizing a Medicare pilot program for cannabis products. This policy shift is expected to ease federal restrictions, improve Tilray's profitability, and attract new customers and institutional investments. Options data for March 20, 2026, implies a 50% move in TLRY, with Wall Street analysts maintaining a "Moderate Buy" rating and price targets indicating over 75% upside.

https://finance.yahoo.com/news/option-traders-pricing-nearly-22-201431483.html

Tilray Brands, Pfizer, Netflix, Lennar Corp. And Tesla: Why These 5 Stocks Are On Investors' Radars Today

This article highlights five stocks — Tilray Brands, Pfizer, Netflix, Lennar Corp., and Tesla — that garnered significant investor attention due to recent news and market performance. Tilray saw a jump on cannabis reclassification speculation, while Pfizer slipped due to a cautious long-term outlook. Netflix gained traction with a podcast partnership, Lennar Corp. delivered mixed earnings, and Tesla surged to a new high on enthusiasm for its autonomous and robotics prospects.

https://www.benzinga.com/news/25/12/49438929/tilray-brands-pfizer-netflix-lennar-corp-and-tesla-why-these-5-stocks-are-on-investors-radars-today

Trending Today

Lamb Weston Holdings Inc. ($LW) Stock Forecast: Down 26.1% Today

Moderna Inc. ($MRNA) Stock Forecast: Up 5.0% Today

Norwegian Cruise Line Holdings Ltd. ($NCLH) Stock Forecast: Up 5.0% Today

Exelon Corporation ($EXC) Stock Forecast: Up 1.0% Today

Electronic Arts Inc. ($EA) Stock Forecast: Up 0.2% Today

Astera Labs Inc ($ALAB) Stock Forecast: Up 5.4% Today

lululemon athletica inc. ($LULU) Stock Forecast: Down 5.4% Today

Carnival Corporation ($CCL) Stock Forecast: Up 5.4% Today

MicroVision Inc. ($MVIS) Stock Forecast: Up 5.2% Today

SolarEdge Technologies, Inc. ($SEDG) Stock Forecast: Down 6.0% Today

Tilray Inc. Price History

28.10.2025 - TLRY Stock was down 5.9%

• Tilray's stock took a hit today following the announcement of a 1-for-10 reverse stock split, which often signals a company's struggle to maintain its stock price.
• Despite posting strong Q1 cannabis growth and market share increases, the news of the reverse stock split overshadowed the positive performance, leading to a bearish trend.
• The market's reaction to the reverse stock split indicates investor concerns about Tilray's future prospects and financial health, contributing to the downward pressure on the stock price.
• Overall, the combination of the reverse stock split news and the market's response to it likely fueled the bearish movement in Tilray's stock today.

19.10.2025 - TLRY Stock was down 5.8%

• Despite posting a sharp profitability turnaround in Q1 and showcasing a strong global growth strategy, TLRY experienced a strong bearish movement.
• The market may have reacted negatively due to profit-taking after a significant run-up in the stock price following the positive Q1 results.
• Investors might be concerned about the sustainability of TLRY's profitability and growth strategy, leading to a sell-off in the stock.
• It's possible that the market was expecting even more impressive results or guidance, causing disappointment and triggering the bearish movement.

09.11.2025 - TLRY Stock was up 7.0%

• The launch of Tilray's Ultimate 2025 Holiday Drink Gift Guide featuring festive beverages may have sparked investor interest, hinting at potential expansion in the company's product range and consumer appeal.
• Following recent declines linked to internal changes, the stock saw a successful recovery, hitting a new 1-year peak, potentially influenced by heightened investor trust in Tilray's strategies and market position.
• Today's positive market outlook for Tilray could also be attributed to the overall industry optimism in the cannabis sector, with investors eyeing growth prospects in a sector shaped by changing consumer tastes and regulations.

24.10.2025 - TLRY Stock was up 6.7%

• The introduction of Good Supply vape products in Québec by Tilray Brands could have sparked investor optimism and interest in the company's expansion into new markets, leading to increased buying activity and driving the stock price higher.
• The positive Q1 results and profitability momentum showcased by Tilray Brands indicate strong financial performance, which likely instilled confidence in investors and contributed to the bullish movement of the stock.
• The publication of a new investor presentation highlighting Tilray's leadership in various industries and its global growth strategy may have attracted new investors and bolstered existing shareholders' belief in the company's future prospects, potentially fueling the upward momentum in the stock price.

03.11.2025 - TLRY Stock was down 10.1%

• Tilray's stock has experienced a 24% drop over the past five sessions due to corporate restructuring and a reverse stock split.
• Negative company developments, including the reverse stock split and market pressures, have influenced the downward movement in TLRY's stock.
• Despite positive Q1 cannabis growth and a strengthened domestic position, the adverse effects of corporate changes have outweighed the positive news, leading to ongoing downward pressure on the stock.
• Investor response to Tilray's uncertainties and obstacles has caused the stock to decline further in line with broader market conditions.

16.11.2025 - TLRY Stock was up 5.8%

• TLRY experienced a substantial surge of 44.1% following potential discussions of a reclassification of marijuana at a federal level. This positive news not only impacted TLRY but also other cannabis stocks like Canopy Growth and Aurora Cannabis.
• The company's recent execution of a 10-for-1 reverse stock split, aimed at reducing its float and ensuring compliance with Nasdaq regulations, also influenced the bullish movement by boosting investor confidence.
• Surpassing its 200-day moving average and holding a Zacks Rank #3 (Hold) indicate a potential long-term bullish trend for TLRY, supported by positive earnings estimate revisions and strategic expansion into new markets.
• While the future looks promising, caution is advised due to the volatility in the cannabis sector. It is advisable for investors to closely monitor the situation until official confirmation and details regarding the potential policy change are disclosed.

19.11.2025 - TLRY Stock was down 23.1%

• Today's bearish movement in TLRY may be due to investors taking profits following a recent surge influenced by discussions of President Trump contemplating cannabis reclassification.
• Though there is optimism about regulatory changes, the speculative nature of the cannabis industry and uncertainties regarding federal legalization may be causing some traders to proceed with caution.
• Volatility in TLRY's stock price could be impacted by option traders anticipating significant year-end movements, leading to short-term market fluctuations.
• It is important for investors to stay informed about any official announcements on cannabis regulations to navigate the current market volatility effectively.

17.11.2025 - TLRY Stock was down 8.1%

• Despite positive developments regarding the potential reclassification of marijuana from Schedule I to Schedule III, Tilray faced a bearish movement.
• The surge in Tilray's stock price post speculations on marijuana reclassification by Trump might have prompted profit-taking actions among investors, leading to the bearish movement.
• Uncertainty surrounding the final reclassification decision and profit-taking activities likely contributed to Tilray's stock price decline today.
• The market sentiment towards Tilray remains optimistic, anticipating future ease in federal restrictions and potential improvements in profitability.

17.11.2025 - TLRY Stock was up 16.2%

• TLRY stock surged by 44.1% due to speculation about a possible reclassification of marijuana as a Schedule III substance through an executive order.
• The surge in TLRY's stock price was driven by optimism about relaxed federal restrictions on cannabis and the potential business opportunities it could bring for companies in the industry.
• Despite the initial rally, the stock price cooled off as White House officials indicated that no final decision had been reached, showcasing the uncertainty surrounding the potential reclassification of marijuana. This led to profit-taking and a moderation in TLRY's price movement.
• Tilray's CEO emphasized the importance of clear regulation in the cannabis industry, especially regarding THC-infused drinks. He highlighted how regulatory clarity could benefit legitimate companies by ensuring quality standards and reducing illicit market activity.

12.11.2025 - TLRY Stock was up 31.7%

• The introduction of Redecan's Amped Live Resin Liquid Diamond 1g 510 cartridges in Canada has sparked enthusiasm and market interest, contributing to Tilray's upward movement.
• Positive developments related to the legalization of home marijuana cultivation in Florida and potential changes in federal cannabis regulations have bolstered investor confidence in Tilray's future outlook.
• Despite facing challenges such as increased expenses and a stock price decline, Tilray's expansion strategies and focus on evolving into a diversified consumer packaged goods (CPG) company have resonated well with traders and investors, driving the bullish market performance observed today.
• The company's adept handling of regulatory shifts and its ability to seize opportunities within the cannabis sector are expected to be key factors influencing its stock performance in the immediate future.

15.11.2025 - TLRY Stock was down 5.2%

• The bearish movement in TLRY today could be attributed to profit-taking by investors after a series of strong bullish movements.
• Despite the recent surge in TLRY's stock price, the lack of a definitive catalyst or news today may have led to a natural correction in the market.
• The mixed views from analysts regarding TLRY's future performance, balancing policy tailwinds with execution challenges, could have also contributed to the bearish movement as investors reassess the stock's potential.

10.11.2025 - TLRY Stock was up 12.0%

• Despite recent difficulties, Tilray (TLRY) witnessed a notable upward movement in the market today.
• This positive shift could be linked to the company's recent initiatives to expand into areas beyond its core cannabis business, such as broadening its beverage and hemp-derived THC product offerings.
• Investors seem hopeful about Tilray's potential for profitability despite ongoing losses, particularly with its focus on non-cannabis sectors to enhance profit margins.
• Today's optimistic market trend may also be driven by speculation regarding potential policy changes concerning the reclassification of cannabis, which could potentially benefit Tilray's future performance.